Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,463
Recruiting: 820
Ph III recruiting: 96
Growth YoY: +6.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 51–71 of 71 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06977594	Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer	not yet recruiting	N/A	1,000	Seoul National University HospitalOTHER	1	Jun 24, 2025	clinicaltrials
NCT07028229	Ultrasound Training Program for Gynecologic Cancer Staging in Residents(Ultra-teaching)	not yet recruiting	N/A	6	Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER	1	Jun 19, 2025